Table 1.
Category | N=134 | (%) | |
---|---|---|---|
Gender |
Male |
112 |
84 |
|
Female |
22 |
16 |
Mean age (years, range) |
|
70 (18–94) |
|
|
Up to 74 |
90 |
67 |
|
75+ |
44 |
33 |
Acquired MRSA |
|
89 |
66 |
Surgical procedure |
54 |
|
|
|
Clean |
4 |
|
|
Clean-contaminated |
32 |
|
|
Contaminated |
18 |
|
Antibiotics use before diagnosis of MRSA |
66 |
|
|
Penicillins |
8 |
|
|
Second-generation cephalosporins |
28 |
|
|
Third-generation cephalosporins |
10 |
|
|
Carbapenems |
22 |
|
|
Fluoroquinolones |
12 |
|
|
Aminoglycosides |
2 |
|
|
Others |
2 |
|
|
Clinically significant MRSA infection |
69 |
51 |
|
Type of infection |
Surgical site |
23 |
|
|
Genitourinary |
15 |
|
|
Blood stream |
11 |
|
|
Gastrointestinal |
11 |
|
|
Respiratory |
9 |
|
Imported MRSA | 45 | 34 |